Analysts study the role of subnuclear NSrp70 in T cell-intervened adaptive immunity Kumar Jeetendra | July 15, 2021 T cell are part of the body’s immune response. The way proteins are spliced in their development and maturation determines how T cells can recognize different pathogens and mount defense against them. Scientists from Korea now highlight the role of NSrp70 in regulating maturation. This protein was previously found in T cells subnuclear space and …
Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations Kumar Jeetendra | September 25, 2021 Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit …
Emerging trends in immunotherapy and cancer Kumar Jeetendra | May 30, 2024 Imagine a world where the battle against cancer no longer relies solely on the blunt instruments of chemotherapy and radiation therapy, which, while effective, often come at a high cost to the patient’s wellbeing. Immuno-oncology (IO) therapy has ushered in a new era by harnessing the body’s innate defenses to combat cancer cells and has …
Breakthroughs Behind the 2025 Nobel Prize in Medicine Kumar Jeetendra | October 9, 2025 The Nobel Prize in Physiology or Medicine awarded in 2025 expressed yet again the value of modern medical research. This year the prize commends the deep accomplishments in our understanding of the human immune system. The prize goes to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking discoveries for the understanding of …
